Scopus BioPharma Inc. (SCPS)

OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
At close: Feb 27, 2026
33.33%
Market Cap 16.83K
Revenue (ttm) n/a
Net Income (ttm) -8.70M
Shares Out 42.08M
EPS (ttm) -0.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 865
Average Volume 3,361
Open 0.0004
Previous Close 0.0004
Day's Range 0.0004 - 0.0006
52-Week Range 0.0003 - 0.0100
Beta 31.08
RSI 47.13
Earnings Date Apr 16, 2026

About Scopus BioPharma

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs. It offers Duet Platform, which consists of signal transducer and activator of transcription 3 (STAT3), a master immune checkpoint inhibitor and toll-like receptor 9 (TLR9), as well as includes CpG-STAT3ASO (DUET-02), CpG-STAT3siRNA (DUET-01), and CpG-STAT3decoy (DUET-03); and that develops a suite of bifunctional oligonucleotides that activate antigen-presenting cells (APCs) ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 13
Stock Exchange OTCMKTS
Ticker Symbol SCPS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.